Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient
We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.PMID:38085151 | DOI:10.18502/ijaai.v22i5.13999 (Source: Iranian Journal of Allergy, Asthma and Immunology)
Source: Iranian Journal of Allergy, Asthma and Immunology - December 12, 2023 Category: Allergy & Immunology Authors: Marco Antonio Yamazaki-Nakashimada Patricia Herrera-Mora Alfonso Mahrx-Bracho Gabriela L ópez-Herrera Juan Carlos Bustamante-Ogando Selma Cecilia Scheffler-Mendoza Source Type: research
Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats
Neuropsychopharmacology, Published online: 12 December 2023; doi:10.1038/s41386-023-01777-zMethylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats (Source: Neuropsychopharmacology)
Source: Neuropsychopharmacology - December 12, 2023 Category: Neurology Authors: Lorissa Lamoureux Joel Beverley Heinz Steiner Michela Marinelli Source Type: research
Ablated Sonic Hedgehog Signaling in the Dentate Gyrus of the Dorsal and Ventral Hippocampus Impairs Hippocampal-Dependent Memory Tasks and Emotion in a Rat Model of Depression
In conclusion, Shh is essential to maintain the functional heterogeneity of dHip and vHip in depressed rat, which was mainly mediating by local changes of dependent activa tion and maturity of immature neurons, respectively. (Source: Molecular Neurobiology)
Source: Molecular Neurobiology - December 12, 2023 Category: Neurology Source Type: research
In silico ecotoxicity assessment of pharmaceutical residues in wastewater following oxidative treatment
In conclusion, in silico extrapolation of experimental findings can provide useful predicted estimates of mixture toxicity. However due to the complex composition of wastewater this in silico approach is a first step to screen for ecotoxicity. It is recommendable to confirm these predictions with ecotoxic bioassays.PMID:38056612 | DOI:10.1016/j.envres.2023.117833 (Source: Environmental Research)
Source: Environmental Research - December 6, 2023 Category: Environmental Health Authors: Martien H F Graumans Wilfred F L M Hoeben Ad M J Ragas Frans G M Russel Paul T J Scheepers Source Type: research
GSE239776 EcoToxChip 2016 LSARP RNASeq database
Contributors : Niladri Basu ; Markus Hecker ; Natacha Hogan ; Jessica Head ; Doug Crump ; Jianguo Xia ; Krittika MittalSeries Type : Expression profiling by high throughput sequencingOrganism : Coturnix japonica ; Lithobates pipiens ; Oncorhynchus mykiss ; Phalacrocorax auritus ; Pimephales promelas ; Xenopus laevisAs part of the EcoToxChip project, 49 distinct exposure studies were conducted on three lab model species (Japanese quail, fathead minnow, African clawed frog) and three ecologically relevant species (double crested cormorant, rainbow trout, northern leopard frog), at multiple life stages (embryo, adult),...
Source: GEO: Gene Expression Omnibus - December 5, 2023 Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Coturnix japonica Lithobates pipiens Oncorhynchus mykiss Phalacrocorax auritus Pimephales promelas Xenopus laevis Source Type: research
Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis
CONCLUSIONS: This meta-analysis indicates that most pharmacotherapies decreased the frequency of binge-eating and vomiting episodes, body weight, and depressive symptoms in BN patients, but the efficacy was not significant. In each drug the efficacy is different, treating different aspects, different symptoms to improve the clinical performance of bulimia nervosa.PMID:38042827 | DOI:10.1186/s40360-023-00713-7 (Source: BMC Pharmacology and Toxicology)
Source: BMC Pharmacology and Toxicology - December 2, 2023 Category: Drugs & Pharmacology Authors: Sijie Yu Yuhan Zhang Chongkai Shen Fei Shao Source Type: research
Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis
CONCLUSIONS: This meta-analysis indicates that most pharmacotherapies decreased the frequency of binge-eating and vomiting episodes, body weight, and depressive symptoms in BN patients, but the efficacy was not significant. In each drug the efficacy is different, treating different aspects, different symptoms to improve the clinical performance of bulimia nervosa.PMID:38042827 | PMC:PMC10693702 | DOI:10.1186/s40360-023-00713-7 (Source: BMC Pharmacology and Toxicology)
Source: BMC Pharmacology and Toxicology - December 2, 2023 Category: Drugs & Pharmacology Authors: Sijie Yu Yuhan Zhang Chongkai Shen Fei Shao Source Type: research
